| 000 | 01576 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250515184456.0 | ||
| 264 | 0 | _c20100310 | |
| 008 | 201003s 0 0 eng d | ||
| 022 | _a1432-0584 | ||
| 024 | 7 |
_a10.1007/s00277-009-0820-9 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBorgerding, Andrea | |
| 245 | 0 | 0 |
_aRituximab retherapy in patients with relapsed aggressive B cell and mantle cell lymphoma. _h[electronic resource] |
| 260 |
_bAnnals of hematology _cMar 2010 |
||
| 300 |
_a283-9 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xadministration & dosage |
| 650 | 0 | 4 | _aAntibodies, Monoclonal, Murine-Derived |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHematopoietic Stem Cell Transplantation _xmethods |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLymphoma, B-Cell _xdrug therapy |
| 650 | 0 | 4 |
_aLymphoma, Large B-Cell, Diffuse _xdrug therapy |
| 650 | 0 | 4 |
_aLymphoma, Mantle-Cell _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aRemission Induction |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aRituximab |
| 650 | 0 | 4 |
_aSalvage Therapy _xmethods |
| 650 | 0 | 4 | _aSurvival Rate |
| 650 | 0 | 4 | _aTransplantation, Homologous |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aHasenkamp, Justin | |
| 700 | 1 | _aGlass, Bertram | |
| 700 | 1 | _aWulf, Gerald | |
| 700 | 1 | _aTrümper, Lorenz | |
| 773 | 0 |
_tAnnals of hematology _gvol. 89 _gno. 3 _gp. 283-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s00277-009-0820-9 _zAvailable from publisher's website |
| 999 |
_c19128227 _d19128227 |
||